• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
COPD Market Forecast Product Image

COPD Market Forecast

  • Published: November 2011
  • 6 pages
  • Datamonitor

New product launches for COPD across the seven major markets will override generic erosion and boost market value from $8.2bn in 2011 to $9.6bn by 2020, representing a positive 2011–20 CAGR of 1.8%. Datamonitor forecasts 14 new product launches in COPD over the next 10 years, altering class dynamics and fracturing a market currently dominated by a handful of therapies.

Features and benefits

- Access Datamonitor’s patient based COPD market forecast for the seven major markets, with transparent methodology and clear assumptions.
- See how each new product launch will impact the market, and where the strongest competition lies.
- Gain insight into COPD market dynamics, and see where untapped market potential remains.
- Understand how currently marketed products are vulnerable to competition in the COPD market, and which products are insulated against brand erosion.

Highlights

- Datamonitor forecasts that sales for COPD will reach $8.2bn in 2011 in the seven major markets, growing to $9.6bn by 2020, representing a positive 2011–20 CAGR of 1.8%, large untapped potential remains. Datamonitor’s survey of 125 pulmonologists shows READ MORE >

OVERVIEW
Summary
Introduction
Features and benefits
Highlights
Key questions answered in this report
Forecasting methodology
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos